LatinoWire

December 13, 2024 02:17 PM Eastern Time

BrightPath Bio e Cellistic annunciano una collaborazione di sviluppo dei processi e della produzione per la sperimentazione clinica di fase 1 di cellule CAR-iNKT derivate dalle iPSC mirate al BCMA

Opens in new window

Download

Full Size JPEG, 1476x542, 211.5 KB
Small JPEG, 480x176, 39.3 KB
Preview JPEG, 144x53, 6.5 KB
Thumbnail JPEG, 120x44, 4.7 KB

Smart Multimedia Gallery

http://www.businesswire.com/multimedia/latinowire/20241213067357/it/5761636/

Share

Email

All News | News with Multimedia > Press Release: BrightPath Bio e Cellistic annunciano una colla...

Get Business Wire News on Your Website

Terms of Use | © 2024 Business Wire